⌘K

Login Start Free

Home/Filings/4/0001628280-23-003428

4//SEC Filing

Litzka Olivier 4

Accession 0001628280-23-003428

CIK 0001933414other

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 9:02 PM ET

Size

5.2 KB

Accession

0001628280-23-003428

Insider Transaction Report

Form 4

Period: 2023-02-09

Mineralys Therapeutics, Inc.MLYS

Director

Transactions

Award
Stock Option
2023-02-09+44,000→ 44,000 total
Exercise: $16.00Exp: 2033-02-09→ Common Stock (44,000 underlying)

Footnotes (1)

[F1]The stock option vests in 36 monthly installments beginning on March 9, 2023.

Documents

1 file

4
wf-form4_167634014769384.xmlPrimary
FORM 4

Issuer

Mineralys Therapeutics, Inc.

CIK 0001933414

Entity typeother

Related Parties

1

filerCIK 0001963940

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 9:02 PM ET
Size: 5.2 KB

View on SEC.gov